Gene · 2822
Papers4,132
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 4,132
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lipidomic analysis of brain and hippocampus from mice fed with high-fat diet and treated with fecal microbiota transplantation. | Nutr Metab (Lond) | 2023 | 36793054 | PubTator, text mining | PubMed |
| Saturated fatty acid- and/or monounsaturated fatty acid-containing phosphatidic acids selectively interact with heat shock protein 27. | J Biol Chem | 2023 | 36791913 | PubTator, text mining | PubMed |
| Identification of Critical Molecular Factors and Side Effects Underlying the Response to Thalicthuberine in Prostate Cancer: A Systems Biology Approach. | Avicenna J Med Biotechnol | 2023 | 36789117 | PubTator, text mining | PubMed |
| Phospholipase D mediates very low-density lipoprotein-induced aldosterone production, in part, via lipin-1. | J Mol Endocrinol | 2023 | 36779781 | PubTator, text mining | PubMed |
| From Genes to Molecules, Secondary Metabolism in Botrytis cinerea: New Insights into Anamorphic and Teleomorphic Stages. | Plants (Basel) | 2023 | 36771642 | PubTator, text mining | PubMed |
| Anti-Cancer Peptides: Status and Future Prospects. | Molecules | 2023 | 36770815 | PubTator, text mining | PubMed |
| Is ICT Development Conducive to Reducing the Vulnerability of Low-Carbon Energy? Evidence from OECD Countries. | Int J Environ Res Public Health | 2023 | 36767809 | PubTator, text mining | PubMed |
| Hearing Care: Safe Listening Method and System for Personal Listening Devices. | Int J Environ Res Public Health | 2023 | 36767527 | PubTator, text mining | PubMed |
| Non-antibiotic prevention and treatment against Acinetobacter baumannii infection: Are vaccines and adjuvants effective strategies? | Front Microbiol | 2023 | 36760499 | PubTator, text mining | PubMed |
INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line. | Br J Cancer | 2023 | 36759720 | PubTator, text mining | PubMed |
| Evolving treatment landscape of immunotherapy in breast cancer: current issues and future perspectives. | Ther Adv Med Oncol | 2023 | 36743524 | PubTator, text mining | PubMed |
| Regulation of mTOR by phosphatidic acid. | Trends Endocrinol Metab | 2023 | 36732094 | PubTator, text mining | PubMed |
| The chemokines CXCL8 and CXCL12: molecular and functional properties, role in disease and efforts towards pharmacological intervention. | Cell Mol Immunol | 2023 | 36725964 | PubTator, text mining | PubMed |
| Changes in Kidney and Liver Volumes in Patients With Autosomal Dominant Polycystic Kidney Disease Before and After Dialysis Initiation. | Mayo Clin Proc Innov Qual Outcomes | 2023 | 36712823 | PubTator, text mining | PubMed |
| PLD plasma plume analysis: a summary of the PSI contribution. | Appl Phys A Mater Sci Process | 2023 | 36699629 | PubTator, text mining | PubMed |
| A "best-in-class" systemic biomarker predictor of clinically relevant knee osteoarthritis structural and pain progression. | Sci Adv | 2023 | 36696492 | PubTator, text mining | PubMed |
| Photoreactive bioorthogonal lipid probes and their applications in mammalian biology. | RSC Chem Biol | 2023 | 36685253 | PubTator, text mining | PubMed |
| Lipidomic and transcriptomic profiles of glycerophospholipid metabolism during Hemerocallis citrina Baroni flowering. | BMC Plant Biol | 2023 | 36683035 | PubTator, text mining | PubMed |
| ATP and nucleic acids competitively modulate LLPS of the SARS-CoV2 nucleocapsid protein. | Commun Biol | 2023 | 36681763 | PubTator, text mining | PubMed |
| mTORC2 Is Activated under Hypoxia and Could Support Chronic Myeloid Leukemia Stem Cells. | Int J Mol Sci | 2023 | 36674750 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2822/papers?page=23